Ghaneya Mesaad Alkhadairi | Hamad Bin Khalifa University
Hamad Bin Khalifa University

FACULTY BIOGRAPHIES

Ghaneya Mesaad Alkhadairi

Dr. Ghaneya Mesaad Alkhadairi (PhD)


Senior Research Associate
Qatar Biomedical Research Institute

  • Phone77763663

Biography

Ghaneya graduated from Qatar University with a Bachelor of Science in Biomedical Sciences in 2006. She received a Qatar Research Leadership Program (QRLP) scholarship from the Qatar National Research Fund (QNRF) in 2016 to pursue her postgraduate education. She holds a Master's and PhD in Biological and Biomedical Sciences from Hamad Bin Khalifa University. Her PhD project focused on exploring the role of cancer testis antigen PRAME in the oncogenesis and tumor progression of breast cancer. She joined Dr. Lawrence Stanton’s team in 2021 as a Senior Research Associate and she is involved in various projects exploring the molecular mechanisms and pathways underlying neurodevelopmental disorders, including Autism Spectrum Disorder (ASD). 
 


Research Interests

  • Patient-derived induced pluripotent cells (iPSCs) and embryonic stem cells (ESCs) models for Studying Autism Spectrum Disorder.
  • CRISPR-Cas9 mediated genome editing and high throughput sequencing approaches.
  • Identification of genes and the molecular mechanisms underlying neurodevelopmental disorders, including autism.

Experience

Senior Research Associate

Neurological Disorders Research Center; Qatar Biomedical Research Institute-Research Development Center; HBKU.

2021 - Present
  • Graduate Scholar - Research Associate

    Qatar Foundation Research and Development

    2016 - 2021
  • Senior Microbiology Technologist

    Department of Laboratory Medicine and Pathology; Hamad Medical Corporation.

    2012 - 2016
  • Medical Microbiology Technologist

    Department of Laboratory Medicine and Pathology; Hamad Medical Corporation.

    2007 - 2012

Education

PhD in Biological and Biomedical Sciences

College of Health and Life Sciences; Hamad Bin Khalifa University-Qatar Foundation; Doha-Qatar.

2021
  • Master in Biological and Biomedical Sciences

    College of Health and Life Sciences; Hamad Bin Khalifa University-Qatar Foundation; Doha-Qatar.

    2017
  • Bachelor of Science in Biomedical Sciences

    Department of Health Sciences-College of Arts and Sciences; Qatar University; Doha-Qatar.

    2006

Selected Publications

  • Alkhadairi, G., A. Naik, R. Thomas, B. Al-Sulaiti, S. Rizly, and J. Decock.

    PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer. J Transl Med 17 (2019): 1–14.

    2019
  • Al-Khadairi,G., and J.Decock.

    Cancertestisantigensandimmunotherapy:Where do we stand in the targeting of PRAME? Cancers (Basel)11 (2019): 1–14.

    2019
  • Naik, A., R. Thomas., G. Al-Khadairi., R. Bacha., W. Hendrickx and and J. Decock.

    Cancer testis antigen PRAME: an-anti cancer target with immunomodulatory potential. JCMM (2021).

    2021
  • Thomas, R., G. Al-Khadairi, and J. Decock.

    Immune checkpoint inhibitors in triple negative breast cancer treatment: promising future prospects. Front. Oncol. 10 (2021).

    2021
  • Thomas, R., G. Al-Khadairi, J. Roelands, W. Hendrickx, S. Dermime, D. Bedognetti, and J. Decock.

    NY-ESO-1 based immunotherapy of cancer: Current perspectives. Front. Immunol. 9 (2018).

    2018